Fecal calprotectin in patients with liver cirrhosis

被引：0
|
作者：
Dinesh Jothimani
Ramya Paramasivam
Mullaiezhili Manoharan
Hemalatha Ramachandran
Subha Muthusamy
Evangeline Simon
Jinesh Ravichandran
Mohamed Rela
机构：
[1] Institute of Liver Disease and Transplantation,
[2] Dr Rela Institute and Medical Centre,undefined
来源：
Indian Journal of Gastroenterology | 2023年 / 42卷
关键词：
Acute-on-chronic liver failure; End-stage liver disease; Fecal calprotectin; Liver cirrhosis; Sepsis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：818 / 823
页数：5
相关论文
共 50 条
  • [21] Fecal Calprotectin Levels in Patients with Colonic Polyposis
    Raffaele Pezzilli
    Alessandra Barassi
    Antonio M. Morselli Labate
    Sergio Finazzi
    Lorenzo Fantini
    Giuseppe Gizzi
    Milvia Lotzniker
    Valeria Villani
    Gianvico Melzi d’Eril
    Roberto Corinaldesi
    Digestive Diseases and Sciences, 2008, 53 : 47 - 51
  • [22] Fecal calprotectin levels in patients with cystic fibrosis
    Agilli, Mehmet
    Aydin, Ibrahim
    Aydin, Fevzi Nuri
    TURKISH JOURNAL OF PEDIATRICS, 2014, 56 (03) : 332 - 332
  • [23] Fecal calprotectin concentration in patients with colorectal carcinoma
    Kristinsson, J
    Roseth, A
    Fagerhol, MK
    Aadland, E
    Schjonsby, H
    Bormer, OP
    Raknerud, N
    Nygaard, K
    DISEASES OF THE COLON & RECTUM, 1998, 41 (03) : 316 - 321
  • [24] Fecal calprotectin levels in patients with colonic polyposis
    Pezzilli, Raffaele
    Barassi, Alessandra
    Labate, Antonio M. Morselli
    Finazzi, Sergio
    Fantini, Lorenzo
    Gizzi, Giuseppe
    Lotzniker, Milvia
    Villani, Valeria
    d'Eril, Gianvico Melzi
    Corinaldesi, Roberto
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (01) : 47 - 51
  • [25] Fecal Calprotectin Levels in Patients with Colonic Polyposis
    Barassi, A.
    Pezzilli, R.
    Morselli-Labate, A. M.
    Finazzi, S.
    Fantini, L.
    Gizzi, G.
    Lotzniker, M.
    Villani, V.
    Corinaldesi, R.
    d'Eril, G. Melzi
    CLINICAL CHEMISTRY, 2009, 55 (06) : A167 - A167
  • [26] Combining fecal calprotectin and fecal Hgb quantification is better than fecal calprotectin for predicting endoscopic disease activity in UC patients
    Kim, Young Bin
    Park, Young Sook
    Jeong, Hee Chan
    Kim, Dong Shin
    Jo, Young Kwan
    Ahn, Sang Bong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 117 - 118
  • [27] Fecal Calprotectin Evaluation in Patients with Ulcerative Colitis
    Tolga Dogan
    Mehmet Agilli
    Digestive Diseases and Sciences, 2015, 60 : 1109 - 1110
  • [28] FECAL CALPROTECTIN IN MONITORING IBD PATIENTS: USEFUL OR NOT?
    Ottaviano, G.
    Wagner, P.
    Moretti, A.
    Macchi, F.
    Arrigo, S.
    Barabino, A.
    Salvatore, S.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E266 - E267
  • [29] Fecal Calprotectin in Pregnancy
    Greenup, Astrid-Jane
    Rosenfeld, Greg
    Leung, Yvette
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : E49 - E50
  • [30] Fecal calprotectin - impact on timing of colonoscopy in IBD patients
    Kanazaki, R.
    Rogge, C.
    Roberts, J.
    Grillas, A.
    Chieng, H.
    Mcdonald, J.
    Lee, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 122 - 122
12345